RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: bone resorption disease
Accession: DOID:0080011
browse the term
Definition: Bone loss due to osteoclastic activity.
Synonyms: exact_synonym: Bone Resorption; Bone Resorptions; Osteoclastic Bone Loss; Osteoclastic Bone Losses
primary_id: MESH:D001862 ; RDO:0004788
For additional species annotation, visit the
Alliance of Genome Resources .
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19934163
NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
G
BMP7
bone morphogenetic protein 7
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17513972
NCBI chr17:57,567,770...57,676,516
Ensembl chr17:57,584,091...57,676,944
G
COL2A1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27028940
NCBI chr 5:78,350,131...78,380,893
Ensembl chr 5:78,350,220...78,380,924
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11985600
NCBI chr 1:120,596,235...120,627,806
Ensembl chr 1:120,367,667...120,695,899
G
GHRL
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29477364
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,316,436...66,452,917
G
PTH
parathyroid hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9881647
NCBI chr 2:45,757,398...45,760,433
Ensembl chr 2:45,757,398...45,760,415
G
PTHLH
parathyroid hormone like hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16769263
NCBI chr 5:45,750,968...45,763,421
Ensembl chr 5:45,751,292...45,763,415
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:15845617 PMID:18496637 PMID:23333834
NCBI chr 4:19,850,212...19,879,132
G
TNFSF11
TNF superfamily member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26319416
NCBI chr11:24,468,011...24,505,421
Ensembl chr11:24,466,586...24,505,422
G
SMAD4
SMAD family member 4
ISO
associated with Juvenile Polyposis Syndrome;DNA:nonsense mutation:exon:p.Y412X (1236C>G) (human)
RGD
PMID:15990641
RGD:12880041
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,514,791...100,628,029
G
ZMPSTE24
zinc metallopeptidase STE24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12913070 PMID:17152860
NCBI chr 6:96,008,307...96,057,131
Ensembl chr 6:96,008,455...96,062,951
G
ALPL
alkaline phosphatase, biomineralization associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20630305
NCBI chr 6:79,589,695...79,649,646
Ensembl chr 6:79,588,659...79,649,648
G
CCR2
C-C motif chemokine receptor 2
ISO
associated with Periodontitis;
RGD
PMID:21241302
RGD:8661687
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,251,959...29,376,346
G
IL10
interleukin 10
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:26270535
RGD:11049527
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,727...67,405,711
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
RGD
PMID:14630900
RGD:10413909
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,159...14,241,197
G
TNF
tumor necrosis factor
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:26270535
RGD:11049527
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,636...23,703,655
G
TNFSF11
TNF superfamily member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19249596
NCBI chr11:24,468,011...24,505,421
Ensembl chr11:24,466,586...24,505,422
G
TNFRSF11A
TNF receptor superfamily member 11a
ISO
OMIM
NCBI chr 1:159,128,039...159,187,476
Ensembl chr 1:159,128,038...159,187,481
G
NOTCH2
notch receptor 2
ISO
OMIM
NCBI chr 4:100,951,522...101,152,348
Ensembl chr 4:100,951,507...101,150,198
G
F12
coagulation factor XII
ISO
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532
NCBI chr 2:80,527,451...80,544,835
Ensembl chr 2:80,526,767...80,546,096
G
SLC34A1
solute carrier family 34 member 1
ISO
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic
ClinVar
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532
NCBI chr 2:80,548,208...80,563,380
Ensembl chr 2:80,548,232...80,563,321
G
F12
coagulation factor XII
ISO
ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic, 1
ClinVar
PMID:28492532
NCBI chr 2:80,527,451...80,544,835
Ensembl chr 2:80,526,767...80,546,096
G
SLC34A1
solute carrier family 34 member 1
ISO
OMIM
NCBI chr 2:80,548,208...80,563,380
Ensembl chr 2:80,548,232...80,563,321
G
SLC9A3R1
SLC9A3 regulator 1
ISO
OMIM
NCBI chr12:6,466,138...6,483,539
Ensembl chr12:6,466,120...6,493,428
G
LRP5
LDL receptor related protein 5
ISO
DNA:mutations:exon:c.3446 T > A (p.L1149Q),c.3553 G > A (p.G1185R)(human)
RGD
PMID:22487062
RGD:12793058
NCBI chr 2:4,533,721...4,653,997
Ensembl chr 2:4,533,593...4,653,945
G
CTSC
cathepsin C
ISO
OMIM
NCBI chr 9:21,726,628...21,761,796
Ensembl chr 9:21,722,035...21,761,473
G
LMNA
lamin A/C
ISO
OMIM
NCBI chr 4:93,899,019...93,927,255
Ensembl chr 4:93,899,026...93,949,398
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18554282
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,175,056...48,188,264
G
ZMPSTE24
zinc metallopeptidase STE24
ISO
ClinVar Annotator: match by term: Mandibuloacral dysostosis
ClinVar
NCBI chr 6:96,008,307...96,057,131
Ensembl chr 6:96,008,455...96,062,951
G
MAFB
MAF bZIP transcription factor B
ISO
OMIM
NCBI chr17:43,408,390...43,411,782
G
BANF1
BAF nuclear assembly factor 1
ISO
OMIM
NCBI chr 2:6,333,451...6,335,326
G
EIF1AD
eukaryotic translation initiation factor 1A domain containing
ISO
ClinVar Annotator: match by term: Nestor-Guillermo progeria syndrome
ClinVar
NCBI chr 2:6,334,882...6,340,125
Ensembl chr 2:6,334,197...6,340,112
G
ANTXR2
ANTXR cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12973667
NCBI chr 8:137,728,849...137,878,336
Ensembl chr 8:137,618,616...137,926,894
G
IBSP
integrin binding sialoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407340
NCBI chr 8:131,208,281...131,222,048
Ensembl chr 8:131,208,282...131,222,050
G
MMP2
matrix metallopeptidase 2
ISO
OMIM:277950, Winchester syndrome
RGD
PMID:16542393
RGD:1601416
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,594...30,086,982
G
MMP7
matrix metallopeptidase 7
ISO
associated with Prostatic Neoplasms
RGD
PMID:15894268
RGD:9685352
NCBI chr 9:33,214,590...33,225,080
Ensembl chr 9:33,214,594...33,225,080
G
PTHLH
parathyroid hormone like hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11054717
NCBI chr 5:45,750,968...45,763,421
Ensembl chr 5:45,751,292...45,763,415
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407340
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878362
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,636...23,703,655
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12548581
NCBI chr 4:19,850,212...19,879,132
G
TNFSF11
TNF superfamily member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18606716
NCBI chr11:24,468,011...24,505,421
Ensembl chr11:24,466,586...24,505,422
G
LPCAT2
lysophosphatidylcholine acyltransferase 2
ISO
ClinVar Annotator: match by term: Multicentric osteolysis, nodulosis and arthropathy
ClinVar
NCBI chr 6:29,999,504...30,056,858
Ensembl chr 6:29,998,488...30,056,862
G
MMP2
matrix metallopeptidase 2
ISO
OMIM
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,594...30,086,982
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
RGD
PMID:10700189
RGD:10047094
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,711
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISO
associated with Hypertension
RGD
PMID:19590507
RGD:2325225
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,639
G
ACTG1
actin gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr12:1,320,355...1,323,219
Ensembl chr12:1,160,350...1,323,217
G
ADCY5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18029912
NCBI chr13:136,965,746...137,133,795
Ensembl chr13:136,973,000...137,135,349
G
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA:increased expression:proximal end of left femur (rat)
RGD
PMID:21542009 PMID:22036861
RGD:6767561 RGD:7245948
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,116...24,228,756
G
ANTXR2
ANTXR cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12973667
NCBI chr 8:137,728,849...137,878,336
Ensembl chr 8:137,618,616...137,926,894
G
ANXA2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,064
G
AR
androgen receptor
treatment
ISO
RGD
PMID:14600402 PMID:18847323
RGD:10043196 RGD:10043198
NCBI chr X:53,609,113...53,806,778
Ensembl chr X:53,609,176...53,805,578
G
ATIC
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:117,617,584...117,649,063
Ensembl chr15:117,617,502...117,649,107
G
ATM
ATM serine/threonine kinase
ISO
RGD
PMID:16644862
RGD:10047420
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,658...36,759,554
G
ATP4B
ATPase H+/K+ transporting subunit beta
treatment
ISO
RGD
PMID:26869358
RGD:14696735
NCBI chr11:78,780,013...78,785,143
Ensembl chr11:78,780,013...78,785,116
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,187,260...54,228,144
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:22648569
RGD:10054093
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,288,544...158,518,879
G
BMP2
bone morphogenetic protein 2
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr17:15,750,487...15,762,982
Ensembl chr17:15,749,835...15,761,215
G
CA2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:51,194,686...51,211,436
Ensembl chr 4:51,193,755...51,211,259
G
CALCB
calcitonin-related polypeptide beta
ISO
RGD
PMID:2502220
RGD:734677
NCBI chr 2:44,043,135...44,048,651
G
CALCR
calcitonin receptor
susceptibility
ISO
DNA:SNP:cds:g.1340T>C (human)
OMIM RGD
PMID:23137636
RGD:10045665
NCBI chr 9:73,279,874...73,403,516
Ensembl chr 9:73,279,911...73,403,434
G
CAP1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 6:95,811,485...95,840,576
Ensembl chr 6:95,812,170...95,840,570
G
CCT2
chaperonin containing TCP1 subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 5:33,858,514...33,873,596
Ensembl chr 5:33,858,572...34,033,939
G
CLEC11A
C-type lectin domain containing 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27976999
NCBI chr 6:55,502,892...55,505,690
Ensembl chr 6:55,496,722...55,506,666
G
COL1A1
collagen type I alpha 1 chain
susceptibility
ISO
DNA:SNP, haplotype:intron:g.2046G>T (human)
OMIM RGD
PMID:23137636
RGD:10045665
NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,003
G
COL1A2
collagen type I alpha 2 chain
ISO
OMIM
NCBI chr 9:74,174,484...74,210,407
Ensembl chr 9:74,173,931...74,210,398
G
CXCR4
C-X-C motif chemokine receptor 4
ISO
RGD
PMID:29882473
RGD:14700776
NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,233
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
ISO
DNA:snps:multiple (human)
RGD
PMID:17002564
RGD:1625350
NCBI chr14:113,805,616...113,820,445
Ensembl chr14:113,805,611...113,812,041
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
ISO
DNA:snps:multiple (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17002564 PMID:20723554
RGD:1625350
NCBI chr 1:120,596,235...120,627,806
Ensembl chr 1:120,367,667...120,695,899
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22337913
NCBI chr17:55,110,546...55,130,328
Ensembl chr17:55,110,590...55,130,363
G
DAAM2
dishevelled associated activator of morphogenesis 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30598549
NCBI chr 7:35,127,245...35,285,933
Ensembl chr 7:35,159,711...35,285,941
G
DBP
D-box binding PAR bZIP transcription factor
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 6:53,986,955...53,993,044
Ensembl chr 6:53,986,959...53,993,020
G
DSPP
dentin sialophosphoprotein
ISO
protein:decreased expression:incisor dental pulp (rat)
RGD
PMID:23974864
RGD:12911019
NCBI chr 8:131,318,187...131,444,274
Ensembl chr 8:131,319,983...131,472,761
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,882...69,401,117
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
RGD
PMID:23281008
RGD:10045609
NCBI chr 6:51,783,537...51,808,898
G
ESR1
estrogen receptor 1
no_association treatment
ISO
DNA:repeat:5' utr:g.-1174(TA)10-27 (human) DNA:SNP:exon:2014G>A (human) DNA:repeat:intron:IVS5+225(CA)18-25 (human) DNA:SNP:intron:397T>C (human) DNA:SNP, haplotype:intron:g.938C>T (human) DNA:SNPs:intron: (rs2234693, rs9340799) (human)
RGD
PMID:10773580 PMID:16530497 PMID:16955786 PMID:17896124 PMID:17953702 PMID:20116372 PMID:21421090 PMID:23137636
RGD:10045665 RGD:10045825 RGD:10045826 RGD:10045828 RGD:10045834 RGD:10045839 RGD:10045841 RGD:8694129
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
ESR2
estrogen receptor 2
susceptibility treatment
ISO
DNA:repeat:3' utr: g.dupCA (human) DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:SNP, haplotypes: :-1213T>C (human)
RGD
PMID:16530497 PMID:16777502 PMID:16955786 PMID:21421090 PMID:22948905
RGD:10045825 RGD:10045841 RGD:1626507 RGD:7364765 RGD:8694129
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,722,164...193,906,565
G
ESRRA
estrogen related receptor alpha
ISO
RGD
PMID:19936213
RGD:10401868
NCBI chr 2:7,803,504...7,812,868
Ensembl chr 2:7,803,510...7,813,836
G
FGA
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 8:74,574,870...74,584,202
Ensembl chr 8:74,574,882...74,584,202
G
FGB
fibrinogen beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 8:74,598,170...74,607,409
Ensembl chr 8:74,594,255...74,607,360
G
G6PD
glucose-6-phosphate dehydrogenase
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:5448 PMID:1303173 PMID:1631957 PMID:1978554 PMID:2321910 PMID:2503817 PMID:2572288 PMID:2836867 PMID:3393536 PMID:3446582 PMID:4359638 PMID:4388132 PMID:6015571 PMID:7949118 PMID:8611726 PMID:8860013 PMID:9858856 PMID:10734064 PMID:12367584 PMID:12737938 PMID:14278484 PMID:16356170 PMID:25741868 PMID:26633385 PMID:27287612 PMID:28492532
NCBI chr X:125,029,147...125,041,040
Ensembl chr X:125,025,257...125,041,033
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,680...64,133,991
G
GHR
growth hormone receptor
treatment
ISO
associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast associated with Cholestasis
RGD
PMID:17647196 PMID:19424739
RGD:10003128 RGD:10003131
NCBI chr16:27,126,300...27,422,618
Ensembl chr16:27,126,286...27,422,268
G
GORAB
golgin, RAB6 interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18997784
NCBI chr 4:80,568,535...80,590,709
Ensembl chr 4:80,567,797...80,590,680
G
GPC6
glypican 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869591
NCBI chr11:62,436,143...63,560,908
Ensembl chr11:62,438,652...63,560,903
G
GPD2
glycerol-3-phosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:63,592,723...63,728,636
Ensembl chr15:63,592,698...63,728,634
G
GPX1
glutathione peroxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,914,932...31,917,335
G
GSN
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,295,713...261,385,287
G
GSR
glutathione-disulfide reductase
ISO
protein:decreased expression:blood
RGD
PMID:19464221
RGD:10401828
NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,989
G
HFE
homeostatic iron regulator
ISO
associated with hemochromatosis
RGD
PMID:26829642
RGD:14746963
NCBI chr 7:20,758,604...20,767,004
Ensembl chr 7:20,758,741...20,768,741
G
HTR2C
5-hydroxytryptamine receptor 2C
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:94,053,415...94,313,352
Ensembl chr X:94,053,456...94,313,356
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,606...55,681,426
G
IGF1
insulin like growth factor 1
treatment
ISO
associated with Diabetes Mellitus, Experimental associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast associated with Cholestasis
RGD
PMID:1466160 PMID:10499542 PMID:17647196 PMID:19424739
RGD:10003127 RGD:10003128 RGD:10003131 RGD:10003132
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,037
G
IGF1R
insulin like growth factor 1 receptor
ISO
RGD
PMID:18079194
RGD:10045888
NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,925...137,690,666
G
IGF2
insulin like growth factor 2
treatment
ISO
RGD
PMID:12162999
RGD:10402555
NCBI chr 2:1,469,183...1,496,417
G
IGFBP3
insulin like growth factor binding protein 3
ISO
protein:decreased expression:serum
RGD
PMID:9284698
RGD:10402579
NCBI chr18:50,002,921...50,009,425
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:94,402,665...94,455,609
Ensembl chr X:94,402,675...94,439,060
G
IL1A
interleukin 1 alpha
ISO
associated with Arthritis, Rheumatoid
RGD
PMID:10555884
RGD:6907107
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8182127
RGD:8551834
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,340...91,511,263
G
IL6R
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15995586
NCBI chr 4:95,322,426...95,381,393
Ensembl chr 4:95,322,426...95,381,282
G
IRS1
insulin receptor substrate 1
ISO
mRNA, protein:decreased expression:multiple
RGD
PMID:22820932
RGD:7207063
NCBI chr15:128,245,846...128,307,321
Ensembl chr15:128,245,846...128,308,335
G
IRS2
insulin receptor substrate 2
ISO
associated with Diabetes Mellitus, Type 2; protein:decreased expression:liver,kidney, muscle:
RGD
PMID:22820932
RGD:7207063
NCBI chr11:76,626,158...76,654,639
Ensembl chr11:76,626,179...76,653,881
G
KL
klotho
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9363890
RGD:10403047
NCBI chr11:9,427,236...9,479,251
Ensembl chr11:9,427,198...9,478,346
G
LEP
leptin
treatment
ISO
human protein in a rat model protein:increased expression:serum (rat) associated with chronic obstructive pulmonary disease; protein:decreased expression:serum
RGD
PMID:11459801 PMID:12609558 PMID:21376149 PMID:24250662
RGD:10053572 RGD:10053615 RGD:10053630 RGD:5128771
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,447
G
LEPR
leptin receptor
susceptibility
ISO
DNA:polymorphisms:cds:p.K109R,Q223R(human)
RGD
PMID:23460508
RGD:10411886
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,798,979...146,896,108
G
LGR4
leucine rich repeat containing G protein-coupled receptor 4
susceptibility
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 17 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:23644456
NCBI chr 2:32,871,837...32,979,150
Ensembl chr 2:32,871,871...32,979,148
G
LOC100127131
tubulin alpha-1C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 5:15,153,516...15,269,783
G
LOC100158003
tubulin alpha-1D chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr15:121,305,563...121,311,919
G
LOC100739163
glutathione S-transferase P-like
ISO
associated with Cystic Fibrosis;DNA:missense mutation:cds:c.313A>G (p.I105V) (human)
RGD
PMID:24593045
RGD:10401929
NCBI chr 2:4,978,761...4,982,233
G
LOC110258578
interleukin-1 beta-like
ISO
RGD
PMID:22997530
RGD:7204491
G
LRCH2
leucine rich repeats and calponin homology domain containing 2
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:94,486,560...94,589,930
Ensembl chr X:94,486,564...94,589,899
G
LRP5
LDL receptor related protein 5
treatment
ISO
OMIM RGD
PMID:21977807 PMID:22704852
RGD:12793063 RGD:7240519
NCBI chr 2:4,533,721...4,653,997
Ensembl chr 2:4,533,593...4,653,945
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16648989 PMID:16936800
NCBI chr13:29,413,886...29,445,751
Ensembl chr13:29,413,886...29,445,737
G
LUZP4
leucine zipper protein 4
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18
ClinVar
PMID:24088041 PMID:26633545
NCBI chr X:94,631,490...94,647,712
G
MAPK14
mitogen-activated protein kinase 14
treatment
ISO
RGD
PMID:18442314
RGD:10045965
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,104...31,862,038
G
MGLL
monoglyceride lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr13:72,480,395...72,568,964
Ensembl chr13:72,479,337...72,568,962
G
MIR152
microRNA mir-152
ISO
miRNA:increased expression:femur
RGD
PMID:31492082
RGD:21066345
NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336
G
MMP9
matrix metallopeptidase 9
ISO
associated with osteoporosis; protein:increased expression:serum
RGD
PMID:19411568
RGD:5129553
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,175,056...48,188,264
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
RGD
PMID:22704852
RGD:7240519
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,119...12,461,078
G
NOG
noggin
ISO
RGD
PMID:12975477
RGD:10414323
NCBI chr12:32,891,321...32,892,206
Ensembl chr12:32,891,321...32,892,206
G
NRIP1
nuclear receptor interacting protein 1
ISO
DNA:silent mutation, haplotype:p.G75G (human)
RGD
PMID:16530497
RGD:10045825
NCBI chr13:179,822,731...179,916,226
Ensembl chr13:179,824,862...179,915,177
G
OPA1
OPA1 mitochondrial dynamin like GTPase
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868
NCBI chr13:130,624,771...130,718,345
Ensembl chr13:130,624,823...130,719,083
G
OXCT1
3-oxoacid CoA-transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr16:26,514,497...26,659,739
Ensembl chr16:26,512,396...26,659,845
G
P4HB
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr12:1,121,816...1,131,291
Ensembl chr12:1,121,793...1,131,291
G
PARK7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 6:68,629,327...68,645,147
Ensembl chr 6:68,629,214...68,645,520
G
PCNA
proliferating cell nuclear antigen
ISO
protein:increased expression:osteoblast:
RGD
PMID:22550338
RGD:10045656
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,125,814...14,185,276
G
PDLIM4
PDZ and LIM domain 4
ISO
OMIM
NCBI chr 2:134,555,367...134,570,356
Ensembl chr 2:134,555,666...134,570,350
G
PGLS
6-phosphogluconolactonase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 2:60,186,690...60,198,037
Ensembl chr 2:60,164,259...60,197,648
G
PKM
pyruvate kinase, muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 7:60,971,807...61,032,780
G
PLEK
pleckstrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 3:73,877,741...73,910,163
Ensembl chr 3:73,877,743...74,005,519
G
PLS3
plastin 3
ISO
OMIM
NCBI chr X:94,885,098...94,971,664
Ensembl chr X:94,885,118...94,971,664
G
PNP
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 7:78,426,838...78,447,029
Ensembl chr 7:78,424,740...78,446,997
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3017235 PMID:4367732 PMID:6143199 PMID:6254450 PMID:19153526
NCBI chr 3:113,661,712...113,668,558
G
PRDX3
peroxiredoxin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr14:129,079,050...129,090,790
Ensembl chr14:129,079,052...129,090,788
G
PSMA2
proteasome 20S subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr18:51,909,399...51,919,859
Ensembl chr18:51,909,473...51,921,243
G
PSMA5
proteasome 20S subunit alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 4:110,695,429...110,717,308
Ensembl chr 4:110,662,692...110,717,293
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:16442794
RGD:10043381
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
PTH
parathyroid hormone
treatment
ISO
protein:decreased expression:serum (rat) CTD Direct Evidence: therapeutic
RGD CTD
PMID:15710971 PMID:17317460 PMID:17882678 PMID:19578808 PMID:21306167 PMID:22312238 PMID:23161222 PMID:30639440
RGD:7242793 RGD:7242907
NCBI chr 2:45,757,398...45,760,433
Ensembl chr 2:45,757,398...45,760,415
G
RAB7B
RAB7B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 9:66,635,636...66,666,034
Ensembl chr 9:66,635,637...66,666,037
G
REN
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18847324
NCBI chr 9:64,809,143...64,822,605
Ensembl chr 9:64,809,146...64,822,636
G
RSU1
Ras suppressor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr10:45,079,014...45,492,073
Ensembl chr10:45,079,047...45,289,422
G
RYR1
ryanodine receptor 1
ISO
ClinVar Annotator: match by term: Osteoporosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:47,339,759...47,458,457
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:22555620 PMID:25377437
RGD:10047129 RGD:10053568
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,157...71,123,299
G
SOD2
superoxide dismutase 2
no_association susceptibility
ISO
DNA:SNPs:5' utr, exon, intron:multiple DNA:SNPs:intron, exon:g.31A>G, g.327C>T (p.A16V) (rs5746094, rs4880) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18924182 PMID:26336112
RGD:11035299
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,651,280...7,691,723
G
TGFB1
transforming growth factor beta 1
treatment
ISO
associated with Uremia;protein:increased expression:osteoblast, osteoclast CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12706579 PMID:17647196
RGD:10003128
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,169...49,349,048
G
TLN1
talin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 1:236,416,041...236,450,978
Ensembl chr 1:236,416,044...236,450,922
G
TNFRSF11A
TNF receptor superfamily member 11a
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 1:159,128,039...159,187,476
Ensembl chr 1:159,128,038...159,187,481
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17667143
NCBI chr 4:19,850,212...19,879,132
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
RGD
PMID:17002564
RGD:1625350
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,149
G
TNFSF11
TNF superfamily member 11
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:17002564 PMID:17882678
RGD:1625350
NCBI chr11:24,468,011...24,505,421
Ensembl chr11:24,466,586...24,505,422
G
TPI1
triosephosphate isomerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 5:63,839,473...63,842,853
Ensembl chr 5:63,837,506...63,843,137
G
TPM4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 2:61,453,721...61,476,781
Ensembl chr 2:61,453,721...61,476,781
G
U2AF1
U2 small nuclear RNA auxiliary factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr13:206,244,772...206,257,697
G
VCL
vinculin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr14:76,700,143...76,811,875
Ensembl chr14:76,700,168...76,811,875
G
VDR
vitamin D receptor
no_association
ISO
associated with Cystic Fibrosis
RGD
PMID:16713399
RGD:4889871
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,267,321
G
WDR1
WD repeat domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18924182
NCBI chr 8:6,413,338...6,452,383
Ensembl chr 8:6,413,347...6,452,346
G
WNT1
Wnt family member 1
susceptibility
ISO
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 16 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:23499309 PMID:23656646
NCBI chr 5:15,010,607...15,015,007
Ensembl chr 5:15,010,985...15,014,079
G
ZDHHC13
zinc finger DHHC-type palmitoyltransferase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20548961
NCBI chr 2:40,251,511...40,310,455
Ensembl chr 2:40,251,246...40,311,553
G
PDGFRB
platelet derived growth factor receptor beta
ISO
OMIM
NCBI chr 2:151,155,753...151,192,818
Ensembl chr 2:151,155,754...151,192,647
G
ACP5
acid phosphatase 5, tartrate resistant
ISO
protein:increased expression:femur (rat)
RGD
PMID:19736603
RGD:2315910
NCBI chr 2:70,206,159...70,209,855
Ensembl chr 2:70,206,159...70,208,328
G
AR
androgen receptor
ISO
RGD
PMID:12593895
RGD:1578682
NCBI chr X:53,609,113...53,806,778
Ensembl chr X:53,609,176...53,805,578
G
BMP15
bone morphogenetic protein 15
susceptibility
ISO
DNA:SNPs, haplotype:5' utr, intron:g.-9C>G, IVS1+905A>G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chr X:44,613,122...44,620,575
Ensembl chr X:44,613,122...44,620,575
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17227729
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
COL1A1
collagen type I alpha 1 chain
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:2037280 PMID:7695699 PMID:7942841 PMID:8218237 PMID:8408653 PMID:8613526 PMID:8669434 PMID:8808594 PMID:9016532 PMID:9067755 PMID:9295084 PMID:9443882 PMID:10931857 PMID:12590186 PMID:15024692 PMID:15024745 PMID:15741671 PMID:15864348 PMID:15931785 PMID:17078022 PMID:17309652 PMID:18412368 PMID:18553566 PMID:18704262 PMID:19344236 PMID:19358256 PMID:21249479 PMID:21567126 PMID:21667357 PMID:22589248 PMID:22753364 PMID:24390061 PMID:25086671 PMID:25741868 PMID:25944380 PMID:25963598 PMID:26177859 PMID:26467025 PMID:27132807 PMID:27509835 PMID:27510842 PMID:27748872 PMID:28378289 PMID:28492532
NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,003
G
COL1A2
collagen type I alpha 2 chain
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:1463018 PMID:1978725 PMID:2052622 PMID:2985635 PMID:7695699 PMID:7860070 PMID:8094076 PMID:8218237 PMID:8786074 PMID:9016532 PMID:9272740 PMID:9399846 PMID:9594376 PMID:9923651 PMID:15172002 PMID:16705691 PMID:17078022 PMID:18028452 PMID:19344236 PMID:21520333 PMID:22589248 PMID:25326637 PMID:25450603 PMID:25741868 PMID:25944380 PMID:26432670 PMID:26604951 PMID:27519266 PMID:28492532
NCBI chr 9:74,174,484...74,210,407
Ensembl chr 9:74,173,931...74,210,398
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
ISO
DNA:snps:exon:multiple (human)
RGD
PMID:17118999
RGD:1600860
NCBI chr 1:120,596,235...120,627,806
Ensembl chr 1:120,367,667...120,695,899
G
ESR1
estrogen receptor 1
susceptibility treatment
ISO
DNA:SNPs, haplotype:intron: (rs2234693, rs9340799) (human) DNA:SNP:intron:IVS1T>C (human)
RGD
PMID:16604479 PMID:16972020
RGD:10045838 RGD:8158082
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
ESR2
estrogen receptor 2
susceptibility
ISO
DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:SNP: :-1213T>C (human) DNA:repeat:intron:IVS5-3919(CA)18-26 (human)
RGD
PMID:16777502 PMID:17945165 PMID:22335445
RGD:10045847 RGD:10045849 RGD:1626507
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,722,164...193,906,565
G
FDPS
farnesyl diphosphate synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31774873
NCBI chr 4:94,500,140...94,514,820
Ensembl chr 4:94,489,215...94,518,408
G
FGF23
fibroblast growth factor 23
ISO
protein:increased expression: :
RGD
PMID:24101107
RGD:10044241
NCBI chr 5:66,028,591...66,038,078
Ensembl chr 5:66,028,776...66,037,739
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:18067744 PMID:24023068
RGD:10402191 RGD:10402540
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,181...190,674,850
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:11063288
RGD:10045861
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,037
G
IGF2
insulin like growth factor 2
treatment
ISO
RGD
PMID:16753016
RGD:10402556
NCBI chr 2:1,469,183...1,496,417
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,340...91,511,263
G
IL7
interleukin 7
treatment
ISO
RGD
PMID:23662133
RGD:10402930
NCBI chr 4:57,677,895...57,744,713
Ensembl chr 4:57,685,069...57,753,797
G
LOC110258578
interleukin-1 beta-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
G
LRP5
LDL receptor related protein 5
ISO
ClinVar Annotator: match by term: Postmenopausal osteoporosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 2:4,533,721...4,653,997
Ensembl chr 2:4,533,593...4,653,945
G
NRIP1
nuclear receptor interacting protein 1
susceptibility
ISO
DNA:silent mutation:cds:p.G75G (human)
RGD
PMID:22335445
RGD:10045849
NCBI chr13:179,822,731...179,916,226
Ensembl chr13:179,824,862...179,915,177
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:11917107
RGD:10003045
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
PTH
parathyroid hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20567999
NCBI chr 2:45,757,398...45,760,433
Ensembl chr 2:45,757,398...45,760,415
G
PTK2B
protein tyrosine kinase 2 beta
ISO
RGD
PMID:17537919
RGD:1642610
NCBI chr14:11,063,662...11,194,196
Ensembl chr14:11,064,492...11,194,194
G
TGFB1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10750555
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,169...49,349,048
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9032749
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,636...23,703,655
G
VDR
vitamin D receptor
treatment
ISO
DNA:SNP:exon: (rs2228570) (human) ClinVar Annotator: match by term: Postmenopausal osteoporosis
RGD ClinVar
PMID:16604479 PMID:25741868
RGD:8158082
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,267,321
G
IFIH1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr15:68,930,998...68,985,145
Ensembl chr15:68,928,244...68,985,074
G
IFIH1
interferon induced with helicase C domain 1
ISO
OMIM
NCBI chr15:68,930,998...68,985,145
Ensembl chr15:68,928,244...68,985,074
G
DDX58
DExD/H-box helicase 58
ISO
OMIM
NCBI chr10:33,891,720...33,976,151
Ensembl chr10:33,865,838...33,933,455
G
DDR2
discoidin domain receptor tyrosine kinase 2
ISO
OMIM
NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,375
G
MMP14
matrix metallopeptidase 14
ISO
OMIM
NCBI chr 7:76,174,502...76,185,931
Ensembl chr 7:76,174,500...76,185,923
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all